ENDRA Life Sciences Management
Management criteria checks 3/4
ENDRA Life Sciences' CEO is Francois Michelon, appointed in Jul 2015, has a tenure of 8.83 years. total yearly compensation is $646.79K, comprised of 60% salary and 40% bonuses, including company stock and options. directly owns 0.044% of the company’s shares, worth $1.40K. The average tenure of the management team and the board of directors is 7.9 years and 8.8 years respectively.
Key information
Francois Michelon
Chief executive officer
US$646.8k
Total compensation
| CEO salary percentage | 60.0% |
| CEO tenure | 8.8yrs |
| CEO ownership | 0.04% |
| Management average tenure | 7.9yrs |
| Board average tenure | 8.8yrs |
Recent management updates
Recent updates
ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks
Sep 29ENDRA Life Sciences receives European patent for TAEUS system
Aug 24Endra Life Sciences Q2 2022 Earnings Preview
Aug 12We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Aug 08
We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Nov 18We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully
Jul 19ENDRA Life Sciences names Irina Pestrikova Principal Financial Officer
Jun 15ENDRA Life Sciences granted 13th U.S. Patent for its TAEUS platform technology
Jan 13ENDRA Life Sciences renews GE Healthcare collaboration agreement
Dec 21Endra Life prices $5M-share offering
Dec 16Endra Life Sciences EPS beats by $0.02
Nov 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$647k | US$388k | -US$10m |
| Sep 30 2023 | n/a | n/a | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$12m |
| Mar 31 2023 | n/a | n/a | -US$13m |
| Dec 31 2022 | US$636k | US$423k | -US$13m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$12m |
| Dec 31 2021 | US$1m | US$374k | -US$11m |
| Sep 30 2021 | n/a | n/a | -US$10m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$11m |
| Dec 31 2020 | US$507k | US$373k | -US$12m |
| Sep 30 2020 | n/a | n/a | -US$19m |
| Jun 30 2020 | n/a | n/a | -US$19m |
| Mar 31 2020 | n/a | n/a | -US$18m |
| Dec 31 2019 | US$979k | US$353k | -US$18m |
| Sep 30 2019 | n/a | n/a | -US$11m |
| Jun 30 2019 | n/a | n/a | -US$10m |
| Mar 31 2019 | n/a | n/a | -US$10m |
| Dec 31 2018 | US$725k | US$340k | -US$10m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$8m |
| Mar 31 2018 | n/a | n/a | -US$7m |
| Dec 31 2017 | US$2m | US$347k | -US$5m |
Compensation vs Market: Francois's total compensation ($USD646.79K) is about average for companies of similar size in the US market ($USD674.46K).
Compensation vs Earnings: Francois's compensation has increased whilst the company is unprofitable.
CEO
Francois Michelon (57 yo)
8.8yrs
Tenure
US$646,787
Compensation
Mr. Francois Michelon has been the Chairman and Chief Executive Officer of ENDRA Life Sciences Inc. since July 2015 and has been President. Mr. Michelon joined ENDRA in 2015. He has healthcare technology e...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 8.8yrs | US$646.79k | 0.044% $ 1.4k | |
| Senior Director of Finance & Secretary | 2.9yrs | US$214.72k | 0% $ 0 | |
| Chief Technology Officer | 17.3yrs | US$531.98k | 0.31% $ 9.8k | |
| Co-Founder | no data | no data | no data | |
| Human Resources Leader | 7yrs | no data | no data |
7.9yrs
Average Tenure
55yo
Average Age
Experienced Management: NDRA's management team is seasoned and experienced (7.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 8.8yrs | US$646.79k | 0.044% $ 1.4k | |
| Independent Director | 11.3yrs | US$75.75k | 0.93% $ 29.4k | |
| Independent Director | 16.3yrs | US$103.35k | 0.074% $ 2.3k | |
| Independent Director | 8.8yrs | US$73.57k | 0.031% $ 994.0 | |
| Independent Director | 4.1yrs | US$65.07k | 0.022% $ 705.6 | |
| Scientific Advisor | 8.8yrs | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | 4.3yrs | no data | no data |
8.8yrs
Average Tenure
57yo
Average Age
Experienced Board: NDRA's board of directors are considered experienced (8.8 years average tenure).